Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Obese or Diabetic Patients With Obstructive Sleep Apnea Syndrome: A Meta-Analysis

In patients with OSAS, serum GLP-1 levels are lower than those of healthy individuals. GLP-1 RAs may significantly reduce AHI in patients with obesity or diabetes. However, given the substantial heterogeneity among studies, the results should be interpreted with caution. Systematic Review Registration: PROSPERO registration No. CRD42024599675.